Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 30 min ago
PreprintCC BY-NC-NDmedRxiv

Daily personalized music listening versus audiobook listening for chronic non-cancer pain in patients on long-term opioid therapy: a randomized controlled trial

1 more authors
  1. 1Neuropharmacology & Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research, Barcelona, Spain; Pharmacology Unit, Department of Pathology

Abstract

Non-pharmacological adjuncts are needed for chronic non-cancer pain in patients receiving long-term opioid therapy. Music listening may reduce pain, but most previous trials have used passive controls, limiting attribution of effects specifically to music. In this open-label, parallel-group, proof-of-concept randomized controlled trial, adults with chronic non-cancer pain receiving long-term opioid therapy were randomized 1:1 to four weeks of daily home-based music or audiobook listening. Analgesic outcomes included pain intensity, responder rates, quantity of pain relief, and multidimensional pain assessment; secondary outcomes included mood, quality of life, global impression of change, and safety. Of 70 participants entering the run-in period, 56 were randomized (28 per group). Adjusting for baseline pain intensity in a linear mixed-effects model, the between-group difference at end of treatment was -1.26 NRS points (95% CI -1.98 to -0.55; p<0.001; d=-0.70), favoring music. A [≥]30% pain-reduction criterion was met by 21.4% of participants in the music group and none in the audiobook group (p=0.023). An exploratory between-group difference in pain intensity favoring music was also observed at follow-up. Other analgesic and secondary outcomes showed no significant between-group differences, although exploratory within-group improvements in mood and health-related quality of life were observed with music. Both groups reported overall improvement in global perceived change, with ratings numerically favoring music. No intervention-related harms were observed. These findings support an analgesic benefit of music beyond the structured listening experience shared with the active comparator. Daily self-administered music listening may represent a feasible, low-cost adjunct for chronic non-cancer pain in patients receiving long-term opioid therapy.

Related

  1. Functional Listening Difficulties in Children With ADHD: Associations With Language Abilities
    Merve Nur SARIYER TEMELLİ, Merve İKİZ BOZSOY, Saniye Tülin FİDAN
    Brain and behaviorPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Three pillars for digital health assessment in LMICs: a mini review of technology benchmarking, digital health literacy, and social media listening
    Anggi Septia Irawan, Bence Döbrössy, Edmond Girasek
    Frontiers in public healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  3. Personalized assistive EMG-controlled virtual reality interface combined with cerebellar-iTBS for post-stroke arm recovery (ERICA): study protocol for a three-arm randomized controlled trial
    Matteo Nocilli, Alex Martino Cinnera, Danny Adrian Spampinato +5
    TrialsPeer-reviewedCC BY-NC-ND 4.0Clinical trials & evidence synthesisCrossref
  4. Using Listening Rooms for Qualitative Data Collection in Medical Science Education Research.
    Emily Green, Beth Lawry, Vanessa Armstrong +1
    Medical science educatorPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCPMC
  5. Efficacy of a personalized, response-based transdiagnostic intervention for emotional disorders delivered via the Internet: a protocol for an adaptive randomized controlled trial
    Fernanda Longo Elia, Azucena García-Palacios, Cristina Botella +4
    Frontiers in psychiatryPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMC
BibTeX
@misc{garridopedrosa2026daily,
  title = {{Daily personalized music listening versus audiobook listening for chronic non-cancer pain in patients on long-term opioid therapy: a randomized controlled trial}},
  author = {J. Garrido-Pedrosa and M. F. Porto and A. Serrano-Afonso and R. Valenzuela and L. Zapata and M. F. Vidal and P. Luna-Diaz and E. Segura and X. Cerda-Company and S. Videla and A. Rodriguez-Fornells and J. Grau-Sanchez and V. Fernandez-Duenas},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.13.26365452},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.13.26365452v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Daily personalized music listening versus audiobook listening for chronic non-cancer pain in patients on long-term opioid therapy: a randomized controlled trial
AU  - J. Garrido-Pedrosa
AU  - M. F. Porto
AU  - A. Serrano-Afonso
AU  - R. Valenzuela
AU  - L. Zapata
AU  - M. F. Vidal
AU  - P. Luna-Diaz
AU  - E. Segura
AU  - X. Cerda-Company
AU  - S. Videla
AU  - A. Rodriguez-Fornells
AU  - J. Grau-Sanchez
AU  - V. Fernandez-Duenas
PY  - 2026
DA  - 2026/10/13
PB  - medRxiv
DO  - 10.64898/2026.10.13.26365452
UR  - https://www.medrxiv.org/content/10.64898/2026.10.13.26365452v1
AB  - Non-pharmacological adjuncts are needed for chronic non-cancer pain in patients receiving long-term opioid therapy. Music listening may reduce pain, but most previous trials have used passive controls, limiting attribution of effects specifically to music. In this open-label, parallel-group, proof-of-concept randomized controlled trial, adults with chronic non-cancer pain receiving long-term opioid therapy were randomized 1:1 to four weeks of daily home-based music or audiobook listening. Analgesic outcomes included pain intensity, responder rates, quantity of pain relief, and multidimensional pain assessment; secondary outcomes included mood, quality of life, global impression of change, and safety. Of 70 participants entering the run-in period, 56 were randomized (28 per group). Adjusting for baseline pain intensity in a linear mixed-effects model, the between-group difference at end of treatment was -1.26 NRS points (95% CI -1.98 to -0.55; p<0.001; d=-0.70), favoring music. A [≥]30% pain-reduction criterion was met by 21.4% of participants in the music group and none in the audiobook group (p=0.023). An exploratory between-group difference in pain intensity favoring music was also observed at follow-up. Other analgesic and secondary outcomes showed no significant between-group differences, although exploratory within-group improvements in mood and health-related quality of life were observed with music. Both groups reported overall improvement in global perceived change, with ratings numerically favoring music. No intervention-related harms were observed. These findings support an analgesic benefit of music beyond the structured listening experience shared with the active comparator. Daily self-administered music listening may represent a feasible, low-cost adjunct for chronic non-cancer pain in patients receiving long-term opioid therapy.
ER  -